Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Garlic oil macerate is a botanical extract produced by macerating crushed garlic cloves in vegetable oil (such as soybean or sunflower oil). This specific preparation method facilitates the chemical transformation of allicin into stable organosulfur compounds, most notably **ajoene** (E- and Z- isomers) and vinyldithiins. It is primarily recognized for its anti-inflammatory and anti-thrombotic properties. The mechanism of action involves the inhibition of the pro-inflammatory transcription factor **nuclear factor kappa B (NF-kB)** and the reduction of platelet activation, potentially through the modulation of fibrinogen binding to the **integrin alpha-IIb/beta-3 (GPIIb/IIIa)** receptor. Clinical research, such as trial NCT00275405, has investigated its effects on inflammatory mediators including C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-a), and various adhesion molecules in healthy subjects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on garlic oil macerate.